Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for 2022 - building momentum to become a leading mid-sized biopharmaceutical company
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - February 7, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for 2022. Commercial highlights QUVIVIQ